MedTrace Logo

Anhidrotic Area and Safety of MEDITOXIN in Healthy Male Valunteers

NCT03647982 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2019-03-26

No results posted yet for this study

Summary

To determine the anhidrotic area and safety of MEDITOXIN

Conditions

  • Anhidrotic Area
  • Hyperhidrosis

Interventions

DRUG

Meditoxin

injection of MEDITOXIN into the intradermal of each contralateral upper back in equal doses

DRUG

Botox

injection of Botox into the intradermal of each contralateral upper back in equal doses

Sponsors & Collaborators

  • Medy-Tox

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-03-20
Primary Completion
2018-10-20
Completion
2018-11-20

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03647982 on ClinicalTrials.gov